ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY side effect
What is ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY ?ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY : Neoral Side Effects Report #5607634-7
Physician from AUSTRALIA reported NEORAL problem on Jan 21, 2008. Male patient, 52 years of age, weighting 149.9 lb, was diagnosed with liver transplant and was treated with NEORAL. After drug was administered, patient experienced the following problems/side effects: biliary anastomosis complication, endoscopic retrograde cholangiopancreatography, hernia, hernia repair, postoperative fever, . NEORAL dosage: 125 MG, BID. During the same period patient was treated with PREDNISOLONE, AZATHIOPRINE. Patient was hospitalized. Patient recovered.
ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY : Forteo Side Effects Report #5377244-8
FORTEO problem was reported by a Consumer or non-health professional from UNITED STATES on June 20, 2007. Female patient, 46 years of age, was diagnosed with osteoporosis and was treated with FORTEO. After drug was administered, patient experienced the following problems/side effects: bile duct stent insertion, cholelithiasis, endoscopic retrograde cholangiopancreatography, hepatic enzyme increased, myalgia, . FORTEO dosage: unknown. Patient was hospitalized. Patient recovered.
ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY : Forteo Side Effects Report #5377244-8
Consumer or non-health professional from UNITED STATES reported FORTEO problem on June 20, 2007. Female patient, 46 years of age, was diagnosed with osteoporosis and was treated with FORTEO. After drug was administered, patient experienced the following problems/side effects: bile duct stent insertion, cholelithiasis, endoscopic retrograde cholangiopancreatography, hepatic enzyme increased, myalgia, . FORTEO dosage: unknown. Patient was hospitalized. Patient recovered.